Morgan Stanley Call 40 OMV 20.12..../ DE000MG5TTV2 /
09/09/2024 18:49:12 | Chg.+0.005 | Bid22:00:34 | Ask22:00:34 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.142EUR | +3.65% | - Bid Size: - |
- Ask Size: - |
OMV AG | 40.00 EUR | 20/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center